FIELD: medicine.
SUBSTANCE: invention refers to pharmacy and medicine. Disclosed is a delayed and / or delayed release oral composition for treating inflammatory intestinal diseases caused by invasion of invasive Escherichia coli (AIEC), including lactoferrin immersed in the core of a reservoir coated with a semipermeable film, or dissolved, and / or dispersed, and / or included in a matrix containing lipids, hydrophilic, amphiphilic substances and mixtures thereof, and the outer coating contains gastric-resistant coating agents (shellac, polymethacrylates, cellulose derivatives) or the semi-permeable film comprises cellulose derivatives.
EFFECT: technical result consists in reducing adhesion of AIEC to intestinal cells Caco-2 and reducing their invasion in said cells.
7 cl, 5 dwg, 9 ex
Authors
Dates
2019-05-30—Published
2014-09-04—Filed